Back to search

Switzerland· 31566010

Maxitrol, Augensalbe

A dexamethason mit antiinfektiva product containing dexamethasonum, neomycinum, polymyxini b sulfas, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC S01CA01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedMaxitrol, AugensalbeATCS01CA01REGISTER NO.31566010PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Dexamethason mit antiinfektiva is registered in 11 of 19 countries.

Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Dexamethason mit antiinfektiva · ATC S01CA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
dexamethasonum, neomycinum, polymyxini B sulfas
Manufacturer
Novartis Pharma Schweiz AG
Country
Switzerland (CH)
ATC code
S01CA01
ATC class
Dexamethason mit Antiinfektiva
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680315660101
    3.5 g
    CHF 13.1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd29db4b-00dd-496a-b228-cbdc167271af
GET /v1/drugs/fd29db4b-00dd-496a-b228-cbdc167271af?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "dexamethasonum 1 mg + neomycinum 3.5 mg + polymyxini b sulfas 6000 UI",
  "valid_from": "1968-03-15",
  "limitations": null,
  "galenic_form": "Augensalbe",
  "therapeutic_area": null,
  "sl_inclusion_date": "1968-03-15",
  "self_retention_pct": 10
}

See everything about dexamethason mit antiinfektiva.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.